Company Filing History:
Years Active: 2023
Title: Martina Ott - Innovator in Cancer Vaccine Development
Introduction
Martina Ott is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines aimed at treating various cancer diseases.
Latest Patents
Martina Ott holds a patent for her invention titled "Histone anti-cancer vaccines." This groundbreaking invention pertains to novel immunogenic peptide sequences that can be utilized as vaccines in the treatment of cancer diseases, including brain cancers such as glioma. The cancer vaccines are designed based on the K27M mutated variant of human Histone 3. The invention also includes fusion proteins comprising the sequences of the cancer vaccines, nucleic acids encoding such vaccines, RNA vaccines, and vectors and host cells that incorporate these sequences. Furthermore, the invention involves T cells and T cell receptors that bind to the cancer vaccines, particularly when presented by the human Major Histocompatibility Complex (MHC). The peptide immunogens elicit a HLA-restricted immune response, making them valuable in the treatment of cancer diseases, especially glioma. Additional aspects of the invention include pharmaceutical compositions and diagnostic methods based on the immunogenic capacity of the disclosed peptides.
Career Highlights
Martina Ott is affiliated with the Deutsches Krebsforschungszentrum, where she continues her research and development efforts in cancer immunotherapy. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
Martina collaborates with esteemed colleagues, including Michael Platten and Theresa Bunse, who contribute to her research endeavors and enhance the impact of her innovations.
Conclusion
Martina Ott's contributions to cancer vaccine development exemplify the potential of innovative research in combating serious diseases. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.